chr1-15484129-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_015849.3(CELA2B):c.493+729T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.532 in 151,882 control chromosomes in the GnomAD database, including 22,491 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.53 ( 22491 hom., cov: 31)
Consequence
CELA2B
NM_015849.3 intron
NM_015849.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.475
Publications
7 publications found
Genes affected
CELA2B (HGNC:29995): (chymotrypsin like elastase 2B) Elastases form a subfamily of serine proteases that hydrolyze many proteins in addition to elastin. Humans have six elastase genes which encode the structurally similar proteins elastase 1, 2, 2A, 2B, 3A, and 3B. Like most of the human elastases, elastase 2B is secreted from the pancreas as a zymogen. In other species, elastase 2B has been shown to preferentially cleave proteins after leucine, methionine, and phenylalanine residues. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.691 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.532 AC: 80768AN: 151766Hom.: 22444 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
80768
AN:
151766
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.532 AC: 80874AN: 151882Hom.: 22491 Cov.: 31 AF XY: 0.530 AC XY: 39360AN XY: 74212 show subpopulations
GnomAD4 genome
AF:
AC:
80874
AN:
151882
Hom.:
Cov.:
31
AF XY:
AC XY:
39360
AN XY:
74212
show subpopulations
African (AFR)
AF:
AC:
28900
AN:
41418
American (AMR)
AF:
AC:
7675
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
AC:
1330
AN:
3468
East Asian (EAS)
AF:
AC:
3131
AN:
5140
South Asian (SAS)
AF:
AC:
1906
AN:
4822
European-Finnish (FIN)
AF:
AC:
5264
AN:
10530
Middle Eastern (MID)
AF:
AC:
110
AN:
292
European-Non Finnish (NFE)
AF:
AC:
31205
AN:
67938
Other (OTH)
AF:
AC:
1054
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1867
3735
5602
7470
9337
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
686
1372
2058
2744
3430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1901
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.